MICROBIX BIOSYSTEMS INC (MBX.CA) Stock Price, Quote, News and Overview
TSX:MBX - Toronto Stock Exchange - CA59501P1045 - Common Stock - Currency: CAD
MBX.CA Quote, Performance and Key Statistics
MICROBIX BIOSYSTEMS INC
TSX:MBX (2/11/2025, 7:00:00 PM)
0.48
-0.01 (-1.03%)
The current stock price of MBX.CA is 0.48 CAD. In the past month the price increased by 14.29%. In the past year, price increased by 17.07%.
MBX.CA Latest News and Analysis
Microbix Schedules Release of Results for Q1 Fiscal 2025
Results Release and Webinar Discussion on Morning of February 13, 2025...
Microbix Receives $2.4 Million from Exercise of Warrants
Further Capital to Assist with Increasing Capabilities, Capacity, and Efficiency...
Microbix Expanding Addressable Market Share with Test Makers Augmenting its Recombinant Antigen Capabilities for Immunoassay Markets
MISSISSAUGA, Ontario, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator,...
Microbix Reports Record Product Sales for Q4 and Fiscal 2024
Full-Year Revenues of $25.4 million and Net Income of $3.5 million...
Microbix Schedules Release of Results for Q4 Fiscal 2024
Results Release and Webinar Discussion on Morning of December 19, 2024...
Microbix Assisting EMQN with Novel Genetic-Test EQA Program
For Rapid Identification of Patients Susceptible to Antibiotic-Induced Hearing Loss...
MBX.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 259.87M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 216.58M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 166.88M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 160.29M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 107.13M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 96.92M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 84.01M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 27.64 | 83.30M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 74.25M | ||
| SVA.CA | SERNOVA CORP | N/A | 53.76M | ||
| MDCX.CA | MEDICUS PHARMA LTD | N/A | 41.77M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 38.24M |
Related stock screener links
About MBX.CA
Company Profile
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The company enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.
Company Info
MICROBIX BIOSYSTEMS INC
265 Watline Avenue
Mississauga ONTARIO L4Z 1P3 CA
CEO: Cameron Groome
Employees: 70
Company Website: https://microbix.com/
Investor Relations: https://microbix.com/investors/press-releases/
Phone: 19053618910
MBX.CA FAQ
What is the stock price of MBX.CA?
The current stock price of MBX.CA is 0.48 CAD.
What is the symbol for MICROBIX BIOSYSTEMS INC stock?
The exchange symbol of MICROBIX BIOSYSTEMS INC is MBX and it is listed on the Toronto Stock Exchange exchange.
On which exchange is MBX.CA stock listed?
MBX.CA stock is listed on the Toronto Stock Exchange exchange.
Is MBX.CA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MBX.CA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MBX.CA.
Does MBX.CA stock pay dividends?
MBX.CA does not pay a dividend.
When does MBX.CA stock report earnings?
MBX.CA will report earnings on 2025-02-13.
What is the Price/Earnings (PE) ratio of MBX.CA?
The PE ratio for MBX.CA is 16. This is based on the reported non-GAAP earnings per share of 0.03 and the current share price of 0.48 CAD.
MBX.CA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to MBX.CA. When comparing the yearly performance of all stocks, MBX.CA is one of the better performing stocks in the market, outperforming 86.29% of all stocks.
MBX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MBX.CA. MBX.CA scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
MBX.CA Financial Highlights
Over the last trailing twelve months MBX.CA reported a non-GAAP Earnings per Share(EPS) of 0.03. The EPS increased by 355.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.86% | ||
| ROA | 9.24% | ||
| ROE | 12.44% | ||
| Debt/Equity | 0.22 |
MBX.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to MBX.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.